- HK$1.00bn
- HK$585.38m
- CNY3.69bn
- 31
- 65
- 10
- 24
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 9.79 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.57 | ||
| Price to Tang. Book | 0.7 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.28 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -17.05% | ||
| Return on Equity | -17.58% | ||
| Operating Margin | -8.51% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 524.44 | 839.12 | 1,756.73 | 2,988.06 | 3,690.54 | 4,593.25 | 5,524.83 | 62.87% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | +373.24 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
ClouDr Group Ltd is a China-based holding company principally engaged in the provision of medical services and products. The Company provides medical supplies and software-as-a-service (SaaS) products to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultations and prescriptions to patients. The Company's product portfolio consists of three major product or service categories. The in-hospital solution mainly includes hospital supplies sales, hospital SaaS and digital marketing services. The pharmacy solution mainly includes pharmacy supplies sales and pharmacy SaaS. The individual chronic condition management solution and others mainly include chronic condition products, premium membership services, as well as insurance brokerage services, advertisement agent services and others.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- August 23rd, 2015
- Public Since
- July 6th, 2022
- No. of Employees
- 1,522
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Stock Exchange of Hong Kong Limited- Shares in Issue
- 535,972,935
- Address
- HANGZHOU
- Web
- https://www.cloudr.cn/
- Phone
- Auditors
- KPMG
Upcoming Events for 9955
Similar to 9955
Acotec Scientific Holdings
Stock Exchange of Hong Kong Limited
Beijing Airdoc Technology Co
Stock Exchange of Hong Kong Limited
AK Medical Holdings
Stock Exchange of Hong Kong Limited
AMCO United Holding
Stock Exchange of Hong Kong Limited
Angelalign Technology
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 20:01 UTC, shares in ClouDr are trading at HK$2.10. This share price information is delayed by 15 minutes.
Shares in ClouDr last closed at HK$2.10 and the price had moved by -72% over the past 365 days. In terms of relative price strength the ClouDr share price has underperformed the FTSE Developed Asia Pacific Index by -73.21% over the past year.
The overall consensus recommendation for ClouDr is Hold. You can view the full broker recommendation list by unlocking its StockReport.
ClouDr does not currently pay a dividend.
ClouDr does not currently pay a dividend.
ClouDr does not currently pay a dividend.
To buy shares in ClouDr you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$2.10, shares in ClouDr had a market capitalisation of HK$1.13bn.
Here are the trading details for ClouDr:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 9955
Based on an overall assessment of its quality, value and momentum ClouDr is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in ClouDr is HK$4.16. That is 98.09% above the last closing price of HK$2.10.
Analysts covering ClouDr currently have a consensus Earnings Per Share (EPS) forecast of CNY0.07 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ClouDr. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -66.69%.
As of the last closing price of HK$2.10, shares in ClouDr were trading -58.47% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The ClouDr PE ratio based on its reported earnings over the past 12 months is 9.79. The shares last closed at HK$2.10.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on ClouDr's directors